02561nam 2200361 450 991076418870332120230327170642.010.5772/intechopen.85732(CKB)4920000001372404(NjHacI)994920000001372404(EXLCZ)99492000000137240420230327d2019 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPrediction of Maternal and Fetal Syndrome of Preeclampsia /Nidhi SharmaLondon :IntechOpen,2019.1 online resource (154 pages)1-83962-257-1 Introductory Chapter: The Multiple Etiologies of Preeclampsia By Nidhi Sharma -- Risk Factor and Biomarker of Preeclampsia By Makmur Sitepu and Jusuf Rachmadsyah -- Placental Adaptation to Hypoxia as a Predictive Marker for Preeclampsia By Sarah I.Y. Ahmed -- Clinical, Biochemical, and Biophysical Markers of Angiogenesis in Preeclampsia By Osredkar Joško and Kumer Kristina --Autophagy in Preeclampsia By Priscila Rezeck Nunes, Leandro Gustavo de Oliveira, Mariana Romão Veiga and Maria Terezinha Serrão Peraçoli -- Alteration in Zeta Potential of Erythrocytes in Preeclampsia Patients By Megha N. Karemore and Jasmine G. Avari -- Biochemical Dysregulation of Pre-Eclampsia and Gestational Diabetes Mellitus By Maria Portelli and Byron Baron -- Adolescence and Preeclampsia By Sergio Rosales-Ortiz, Olivia Sánchez Rodríguez, Mario Borbolla-Ramos and Karen D. García-Pérez.The clinical syndrome of preeclampsia is due to vasospasm, endothelial dysfunction, and altered red cell zeta potential. It is a culmination of multiple etiologies and pathophysiologies modified by epigenetics and the human immune system. Since the etiology and pathogenesis of preeclampsia are segregated and multifactorial, there is no single clinical, biophysical, or biochemical marker that can predict all types of this condition. This book provides a set of tentative specific prediction markers that can be used to identify different subtypes of preeclampsia, classify pathogenesis, categorize treatment, and identify early signs of complications.PreeclampsiaPreeclampsia.618.36132Sharma Nidhi1103366NjHacINjHaclBOOK9910764188703321Prediction of Maternal and Fetal Syndrome of Preeclampsia3645246UNINA